331 related articles for article (PubMed ID: 33383713)
1. Immune-Based Therapies and the Role of Microsatellite Instability in Pancreatic Cancer.
Ghidini M; Lampis A; Mirchev MB; Okuducu AF; Ratti M; Valeri N; Hahne JC
Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33383713
[TBL] [Abstract][Full Text] [Related]
2. Lynch Syndrome and MSI-H Cancers: From Mechanisms to "Off-The-Shelf" Cancer Vaccines.
Roudko V; Cimen Bozkus C; Greenbaum B; Lucas A; Samstein R; Bhardwaj N
Front Immunol; 2021; 12():757804. PubMed ID: 34630437
[TBL] [Abstract][Full Text] [Related]
3. Challenges and perspectives for immunotherapy in oesophageal cancer: A look to the future (Review).
Lampis A; Ratti M; Ghidini M; Mirchev MB; Okuducu AF; Valeri N; Hahne JC
Int J Mol Med; 2021 Jun; 47(6):. PubMed ID: 33846775
[TBL] [Abstract][Full Text] [Related]
4. Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency.
Cohen R; Buhard O; Cervera P; Hain E; Dumont S; Bardier A; Bachet JB; Gornet JM; Lopez-Trabada D; Dumont S; Kaci R; Bertheau P; Renaud F; Bibeau F; Parc Y; Vernerey D; Duval A; Svrcek M; André T
Eur J Cancer; 2017 Nov; 86():266-274. PubMed ID: 29055842
[TBL] [Abstract][Full Text] [Related]
5. Current Microsatellite Instability Testing in Management of Colorectal Cancer.
Sun BL
Clin Colorectal Cancer; 2021 Mar; 20(1):e12-e20. PubMed ID: 32888812
[TBL] [Abstract][Full Text] [Related]
6. Microsatellite instability in colorectal cancer: overview of its clinical significance and novel perspectives.
Battaglin F; Naseem M; Lenz HJ; Salem ME
Clin Adv Hematol Oncol; 2018 Nov; 16(11):735-745. PubMed ID: 30543589
[TBL] [Abstract][Full Text] [Related]
7. A Multi-cohort Study of the Prognostic Significance of Microsatellite Instability or Mismatch Repair Status after Recurrence of Resectable Gastric Cancer.
An JY; Choi YY; Lee J; Hyung WJ; Kim KM; Noh SH; Choi MG; Cheong JH
Cancer Res Treat; 2020 Oct; 52(4):1153-1161. PubMed ID: 32599987
[TBL] [Abstract][Full Text] [Related]
8. [Lynch syndrome and microsatellite instability: a review].
Desselle F; Verset G; Polus M; Louis E; Van Daele D
Rev Med Liege; 2012 Dec; 67(12):638-43. PubMed ID: 23342874
[TBL] [Abstract][Full Text] [Related]
9. Immune Microenvironment in Microsatellite-Instable Endometrial Cancers: Hereditary or Sporadic Origin Matters.
Pakish JB; Zhang Q; Chen Z; Liang H; Chisholm GB; Yuan Y; Mok SC; Broaddus RR; Lu KH; Yates MS
Clin Cancer Res; 2017 Aug; 23(15):4473-4481. PubMed ID: 28264871
[No Abstract] [Full Text] [Related]
10. Clinical significance of microsatellite instability in colorectal cancer.
Kloor M; Staffa L; Ahadova A; von Knebel Doeberitz M
Langenbecks Arch Surg; 2014 Jan; 399(1):23-31. PubMed ID: 24048684
[TBL] [Abstract][Full Text] [Related]
11. Differences in histological features and PD-L1 expression between sporadic microsatellite instability and Lynch-syndrome-associated disease in Japanese patients with colorectal cancer.
Yamada R; Yamaguchi T; Iijima T; Wakaume R; Takao M; Koizumi K; Hishima T; Horiguchi SI
Int J Clin Oncol; 2018 Jun; 23(3):504-513. PubMed ID: 29327160
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic intraductal papillary mucinous neoplasm in a patient with Lynch syndrome.
Flanagan MR; Jayaraj A; Xiong W; Yeh MM; Raskind WH; Pillarisetty VG
World J Gastroenterol; 2015 Mar; 21(9):2820-5. PubMed ID: 25759555
[TBL] [Abstract][Full Text] [Related]
13. Hereditary prostate cancer as a feature of Lynch syndrome.
Bauer CM; Ray AM; Halstead-Nussloch BA; Dekker RG; Raymond VM; Gruber SB; Cooney KA
Fam Cancer; 2011 Mar; 10(1):37-42. PubMed ID: 20872076
[TBL] [Abstract][Full Text] [Related]
14. Expending Role of Microsatellite Instability in Diagnosis and Treatment of Colorectal Cancers.
Chang L; Chang M; Chang HM; Chang F
J Gastrointest Cancer; 2017 Dec; 48(4):305-313. PubMed ID: 28699072
[TBL] [Abstract][Full Text] [Related]
15. Prognosis of microsatellite instability and/or mismatch repair deficiency stage III colon cancer patients after disease recurrence following adjuvant treatment: results of an ACCENT pooled analysis of seven studies.
Taieb J; Shi Q; Pederson L; Alberts S; Wolmark N; Van Cutsem E; de Gramont A; Kerr R; Grothey A; Lonardi S; Yoshino T; Yothers G; Sinicrope FA; Zaanan A; André T
Ann Oncol; 2019 Sep; 30(9):1466-1471. PubMed ID: 31268130
[TBL] [Abstract][Full Text] [Related]
16. Microsatellite Instability in Russian Patients with Colorectal Cancer.
Shubin V; Shelygin Y; Achkasov S; Sushkov O; Nazarov I; Ponomarenko A; Alimova I; Loginova A; Tsukanov A
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806077
[TBL] [Abstract][Full Text] [Related]
17. Irrelevance of microsatellite instability in the epidemiology of sporadic pancreatic ductal adenocarcinoma.
Laghi L; Beghelli S; Spinelli A; Bianchi P; Basso G; Di Caro G; Brecht A; Celesti G; Turri G; Bersani S; Schumacher G; Röcken C; Gräntzdörffer I; Roncalli M; Zerbi A; Neuhaus P; Bassi C; Montorsi M; Scarpa A; Malesci A
PLoS One; 2012; 7(9):e46002. PubMed ID: 23029359
[TBL] [Abstract][Full Text] [Related]
18. Safety of Nivolumab plus Low-Dose Ipilimumab in Previously Treated Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer.
Morse MA; Overman MJ; Hartman L; Khoukaz T; Brutcher E; Lenz HJ; Atasoy A; Shangguan T; Zhao H; El-Rayes B
Oncologist; 2019 Nov; 24(11):1453-1461. PubMed ID: 31147488
[TBL] [Abstract][Full Text] [Related]
19. An updated review of microsatellite instability in the era of next-generation sequencing and precision medicine.
Yamamoto H; Imai K
Semin Oncol; 2019 Jun; 46(3):261-270. PubMed ID: 31537299
[TBL] [Abstract][Full Text] [Related]
20. Lynch syndrome-associated epithelial ovarian cancer and its immunological profile.
Rasmussen M; Lim K; Rambech E; Andersen MH; Svane IM; Andersen O; Jensen LH; Nilbert M; Therkildsen C
Gynecol Oncol; 2021 Sep; 162(3):686-693. PubMed ID: 34275654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
